Citadel Advisors »

Mira Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mira Pharmaceuticals (MIRA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mira Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mira Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $112k 98k 1.14
2024-06-30 $16k 24k 0.66

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Mira Pharmaceuticals

Cross Staff Investments
Vanguard Group
Geode Capital Management
BlackRock
Suncoast Equity Management
First American Bank
State Street Corporation
Renaissance Technologies
Two Sigma Investments
J.w. Cole Advisors
Northern Trust
XTX Topco
International Assets Investment Management
Commonwealth Equity Services
Creative Planning

View all funds holding Mira Pharmaceuticals